General and efficient copper-catalyzed three-component coupling reaction towards imidazoheterocycles: One-pot synthesis of alpidem and zolpidem

Angewandte Chemie - International Edition

Volumn 49, Issue 15, 2010, Pages 2743-2746

  Chernyak, Natalia ^a   Gevorgyan, Vladimir ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cyclization; Heterocycles; Homogeneous catalysis; Imidazopyridines; Multicomponent reactions

Indexed keywords

HETEROCYCLES; HOMOGENEOUS CATALYSIS; IMIDAZOPYRIDINES; MULTI-COMPONENT REACTIONS; ONE-POT SYNTHESIS; SYNTHETIC UTILITY; THREE-COMPONENT COUPLING REACTION;

AMIDES; CATALYSIS; PYRIDINE; REACTION KINETICS; SYNTHESIS (CHEMICAL);

CYCLIZATION;

ALPIDEM; ANXIOLYTIC AGENT; COPPER; HETEROCYCLIC COMPOUND; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINOLINE; QUINOLINE DERIVATIVE; ZOLPIDEM;

ARTICLE; CATALYSIS; CHEMISTRY; CYCLIZATION; SYNTHESIS;

ANTI-ANXIETY AGENTS; CATALYSIS; COPPER; CYCLIZATION; HETEROCYCLIC COMPOUNDS; IMIDAZOLES; PYRIDINES; PYRIMIDINES; QUINOLINES;

EID: 77950497504     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.200907291     Document Type: Article

References (42)

1. For a general review on the chemistry of Imidazopyridine derivatives, see: F. Couty, G. Evano in Comprehensive Heterocyclic Chemistry III, Vol.11 (Eds.: A. R. Katritzky, C. A. Ramsden, E. F. V. Scriven, R. J. K. Taylor), Elsevier, Oxford, 2008, pp. 409-499, and references therein.
2. For selected examples of biologically active imidazo[1.2-a]pyridyl derivatives, see: a) T. Okubo, R. Yoshikawa, S. Chaki. S. Okuyamac, A. Nakazato, Bioorg. Med. Chem. 2004, 12, 423;
3. b) A. N. Jain, J. Med. Chem. 2004, 47, 947;
4. c) T. Swainston Harrison, G. M. Keating, CNS Drugs 2005, 19, 65;
5. d) N. Hsua, S. K. Jha, T. Coleman. M. G. Frank, Behav. Brain Res. 2009, 201, 233;
6. e) M. H. Wiegand. Drugs 2008, 68, 2411;
7. f) S. M. Hanson, E. V. Morlock, K. A. Satyshur, C. Czajkowski, J. Med. Chem. 2008, 51, 7243;
8. g) J. B. Véron, H. Allouchi, C. Enguehard Gueiffier, R. Snoeck, G. A. E. De Clercq, A. Gueiffier, Bioorg. Med. Chem. 2008, 16, 9536.
9. For selected examples on the synthesis of imidazo[1,2-a]pyridine derivatives, see: a) C. J. R. Fookes, T. Q. Pham, F. Mattner, I. Greguric, C. Loc'h, X. Liu, P. Berghofer, R. Shepherd, M. C. Gregoire, A. Katsifis, J. Med. Chem. 2008, 51, 3700;
10. b) N. Denora, V. Laquintana, M. G. Pisu, R. Dore, L. Murru, A. Latrofa, G. Trapani, E. Sanna, J. Med. Chem. 2008, 51, 6876;
11. c) V. Laquintana, N. Denora, A. Lopedota, H. Suzuki, M. Sawada, M. Serra. G. Biggio, A. Latrofa, G. Trapani, G. Liso, Bioconjugate Chem. 2007, 18, 1397;
12. d) G. Trapani, V. Laquintana, N. Denora, A. Trapani, A. Lopedota, A. Latrofa, M. Franco, M. Serra, M. G. Pisu, I. Floris, E. Sanna, G. Biggio, G. Liso, J. Med. Chem. 2005, 48, 292.
13. For multicomponent approaches limited to the synthesis of 3aminoimidazo[1,2-a]pyridine derivatives, see: a) A. L. Rousseau, P. Matlaba, C. J. Parkinson. Tetrahedron Lett. 2007, 48, 4079;
14. b) E. F. DiMauro, J. M. Kennedy, J. Org. Chem. 2007, 72, 1013;
15. c) M. A. Lyon, T. S. Kercher, Org. Lett. 2004, 6, 4989;
16. d) T. Masquelin, H. Bui, B. Brickley, G. Stephenson, J. Schwerkosked, C. Hulmea, Tetrahedron Lett. 2006, 47, 2989.
17. For examples on the synthesis of fused heterocycles by copper and palladium-catalyzed 5-exo-dig heteroannulations, see: a) R. Martin, M. Rodriguez Rivero, S. L. Buchwald, Angew. Chem. 2006, 118, 7237;
18. Angew. Chem. Int. Ed. 2006, 45, 7079;
19. b) M. Bakherad, H. Nasr-Isfahani, A. Keivanloo, G. Sang, Tetrahedron Lett. 2008, 49, 6188;
20. c) M. Bakherad. H. Nasr-Isfahani, A. Keivanloo, N. Doostmohammadi. Tetrahedron Lett. 2008, 49, 3819.
21. For selected examples of copper-catalyzed syntheses of propargylamine derivatives by a TCC reaction, see: a) M. K. Patil, M. Keller, B. M. Reddy, P. Pale, J. Sommer, Eur. J. Org. Chem. 2008, 4440;
22. b) M. Lakshmi Kantam. S. Laha, J. Yadav, S. Bhargava, Tetrahedron Lett. 2008, 49, 3083;
23. for gold-catalyzed, see: c) V. K. Y. Loa, K. K. Y. Kung, M. K. Wong, C. M. Che. J. Organomet. Chem. 2009, 694, 583:
24. d) X. Zhang. A. Corma. Angew. Chem. 2008, 120, 4430;
25. Angew. Chem. Int. Ed. 2008, 47, 4358;
26. e) M. Kidwai, V. Bansal, A. Kumarb, S. Mozumdar, Green Chem. 2007, 9, 742;
27. for other transition-metal-catalyzed reactions, see: f) Y. Zhang. P. Li. M. Wang. L. Wang, J. Org. Chem. 2009, 74, 4364;
28. g) P. Li, Y. Zhang. L. Wang, Chem. Eur. J. 2009, 15, 2045 :
29. for the enantioselective version, see : h) C. J. Li, C. Wei, Chem. Commun. 2002, 268;
30. i) N. Gommermann, C. Koradin, K. Polborn, P. Knochel, Angew. Chem. 2003, 115, 5941;
31. Angew. Chem. Int. Ed. 2003, 42, 5763;
32. j) T. F. Knöpfel, P. Aschwanden, T. Ichikawa, T. Watanabe, E. M. Carreira, Angew. Chem. 2004, 116, 6097:
33. Angew. Chem. Int. Ed. 2004, 43, 5971;
34. k) A. Bisai, V. K. Singh. Org. Lett. 2006, 8, 2405.
35. B. Yan, Y. Liu, Org. Lett. 2007, 9, 4323.
36. 2 is more efficient for the subsequent 5-exo-dig cyclization of 4 to give the imidazo[1,2-a]pyridyl core 5. See Ref. [9] and the discussion therein.
37. II binary system in the synthesis of benzofuran derivatives, see: N. Sakai, N. Uchida, T. Konakahara, Tetrahedron Lett. 2008, 49, 3437.
38. See the Supporting Information for details.
39. a) Y. Sumalatha, T. R. Reddy, P. P. Reddy, B. Satyanarayana, ARKIVOC 2008, 2, 315;
40. b) J. Allen, G. Parent, A. Tizot, J. Labelled Compd. Radlopharm. 1986, 23, 807;
41. c) J. Allen, A. Tizot, J. Labelled Compd. Radlopharm. 1986, 23, 393;
42. for patents, see the Supporting Information.